A citation-based method for searching scientific literature

Bin Xiao, Daxiang Chen, Quan Zhou, Jianfeng Hang, Weiyun Zhang, Zhenzhan Kuang, Zhaohui Sun, Linhai Li. BMC Cancer 2019
Times Cited: 17







List of co-cited articles
105 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance.
Hee Jin Chang, Byong Chul Yoo, Seok-Byung Lim, Seung-Yong Jeong, Woo Ho Kim, Jae-Gahb Park. Clin Cancer Res 2005
92
29

Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.
Amit K Srivastava, Ananya Banerjee, Tiantian Cui, Chunhua Han, Shurui Cai, Lu Liu, Dayong Wu, Ri Cui, Zaibo Li, Xiaoli Zhang,[...]. Cancer Res 2019
45
29

MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway.
Shuang Pan, Fu Ren, Lei Li, Dahua Liu, Yao Li, Aimei Wang, Weihong Li, Yongyan Dong, Wenjuan Guo. Exp Cell Res 2020
24
29


A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
Janice M Mehnert, Ann W Silk, J H Lee, Liesel Dudek, Byeong-Seon Jeong, Jiadong Li, Jason M Schenkel, Evita Sadimin, Michael Kane, Hongxia Lin,[...]. Pigment Cell Melanoma Res 2018
29
23


miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16.
Jianhui Shi, Gang An, Ying Guan, Tianli Wei, Zhibin Peng, Min Liang, Yansong Wang. Cancer Cell Int 2019
25
23

Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics.
Wanrong Yi, Mei-Juan Tu, Zhenzhen Liu, Chao Zhang, Neelu Batra, Ai-Xi Yu, Ai-Ming Yu. Acta Pharm Sin B 2020
34
23

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo.
Atif J Khan, Stephanie LaCava, Monal Mehta, Devora Schiff, Aditya Thandoni, Sachin Jhawar, Shabbar Danish, Bruce G Haffty, Suzie Chen. Oncotarget 2019
11
27

Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
Antonietta Arcella, Giulia Carpinelli, Giuseppe Battaglia, Mara D'Onofrio, Filippo Santoro, Richard Teke Ngomba, Valeria Bruno, Paola Casolini, Felice Giangaspero, Ferdinando Nicoletti. Neuro Oncol 2005
85
17

Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer.
Cecilia L Speyer, Ali H Hachem, Ali A Assi, Jennifer S Johnson, John A DeVries, David H Gorski. PLoS One 2014
37
17

The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells.
Nikolaos Pissimissis, Efstathia Papageorgiou, Peter Lembessis, Athanasios Armakolas, Michael Koutsilieris. Anticancer Res 2009
41
17

Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells.
Shahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, Kristopher Attwood, Ray Scioneaux, Dhatchayini Subramani, Charles Manhardt, Giovanni D Lorusso, Stacey S Willard, Hillary Thompson,[...]. Clin Cancer Res 2012
88
17

Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.
Cecilia L Speyer, Mahdy A Nassar, Ali H Hachem, Miriam A Bukhsh, Waris S Jafry, Rafa M Khansa, David H Gorski. Breast Cancer Res Treat 2016
26
17

Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.
Kyu Yeong Choi, Kai Chang, James M Pickel, John D Badger, Katherine W Roche. Proc Natl Acad Sci U S A 2011
67
17

Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.
Sonia C Dolfi, Daniel J Medina, Aparna Kareddula, Bhavna Paratala, Ashley Rose, Jatinder Dhami, Suzie Chen, Shridar Ganesan, Gillian Mackay, Alexei Vazquez,[...]. Oncotarget 2017
14
21

AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1).
Seung-Shick Shin, Brian A Wall, James S Goydos, Suzie Chen. Pigment Cell Melanoma Res 2010
37
17

Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.
Y Ohtani, T Harada, Y Funasaka, K Nakao, C Takahara, M Abdel-Daim, N Sakai, N Saito, C Nishigori, A Aiba. Oncogene 2008
61
17

Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.
Seung-Shick Shin, Jin Namkoong, Brian A Wall, Ryan Gleason, Hwa Jin Lee, Suzie Chen. Pigment Cell Melanoma Res 2008
64
17

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
Jin Namkoong, Seung-Shick Shin, Hwa Jin Lee, Yarí E Marín, Brian A Wall, James S Goydos, Suzie Chen. Cancer Res 2007
142
17

Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
Cecilia L Speyer, Jennifer S Smith, Malathi Banda, John A DeVries, Tassia Mekani, David H Gorski. Breast Cancer Res Treat 2012
87
17

Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.
Jessica L F Teh, Raj Shah, Stephanie La Cava, Sonia C Dolfi, Madhura S Mehta, Sameera Kongara, Sandy Price, Shridar Ganesan, Kenneth R Reuhl, Kim M Hirshfield,[...]. Breast Cancer Res Treat 2015
20
17

Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells.
Mara D'Onofrio, Antonietta Arcella, Valeria Bruno, Richard T Ngomba, Giuseppe Battaglia, Vincenza Lombari, Giuseppe Ragona, Antonella Calogero, Ferdinando Nicoletti. J Neurochem 2003
67
17

Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
Chi Zhang, Xian-rui Yuan, Hao-yu Li, Zi-jin Zhao, Yi-wei Liao, Xiang-yu Wang, Jun Su, Shu-shan Sang, Qing Liu. Cell Physiol Biochem 2015
50
17

Metabotropic glutamate receptors in cancer.
Lumeng J Yu, Brian A Wall, Janet Wangari-Talbot, Suzie Chen. Neuropharmacology 2017
54
17

The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.
Maithao N Le, Joseph L-K Chan, Stephen A Rosenberg, Adam S Nabatian, Kim T Merrigan, Karine A Cohen-Solal, James S Goydos. J Invest Dermatol 2010
52
17

Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy.
Wei Ma, Chao-Nan Ma, Nan-Nan Zhou, Xian-Dong Li, Yi-Jie Zhang. Sci Rep 2016
48
17



Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
C Ciceroni, A Arcella, P Mosillo, G Battaglia, E Mastrantoni, M A Oliva, G Carpinelli, F Santoro, P Sale, L Ricci-Vitiani,[...]. Neuropharmacology 2008
36
11

Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models.
Kaleb Yohay, Betty Tyler, Kyle D Weaver, Andrea C Pardo, Dan Gincel, Jaishri Blakeley, Henry Brem, Jeffrey D Rothstein. J Neurosurg 2014
19
11

Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo.
Atif J Khan, Brian Wall, Stuti Ahlawat, Camille Green, Devora Schiff, Janice M Mehnert, James S Goydos, Suzie Chen, Bruce G Haffty. Clin Cancer Res 2011
34
11

Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.
C Ciceroni, M Bonelli, E Mastrantoni, C Niccolini, M Laurenza, L M Larocca, R Pallini, A Traficante, P Spinsanti, L Ricci-Vitiani,[...]. Cell Death Differ 2013
46
11

Structural insights into the activation of metabotropic glutamate receptors.
Antoine Koehl, Hongli Hu, Dan Feng, Bingfa Sun, Yan Zhang, Michael J Robertson, Matthew Chu, Tong Sun Kobilka, Toon Laeremans, Jan Steyaert,[...]. Nature 2019
146
11

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.
Malathi Banda, Cecilia L Speyer, Sara N Semma, Kingsley O Osuala, Nicole Kounalakis, Keila E Torres Torres, Nicola J Barnard, Hyunjin J Kim, Bonnie F Sloane, Fred R Miller,[...]. PLoS One 2014
28
11

miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Martine Croset, Francesco Pantano, Casina W S Kan, Edith Bonnelye, Françoise Descotes, Catherine Alix-Panabières, Charles-Henri Lecellier, Richard Bachelier, Nathalie Allioli, Saw-See Hong,[...]. Cancer Res 2018
103
11

Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Yao-Yin Chang, Wen-Hung Kuo, Jui-Hui Hung, Chien-Yueh Lee, Yung-Hua Lee, Ya-Chu Chang, Wen-Chun Lin, Cheng-Ying Shen, Chiun-Sheng Huang, Fon-Jou Hsieh,[...]. Mol Cancer 2015
79
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
Dengfeng Li, Hongming Song, Tianqi Wu, Dan Xie, Jiashu Hu, Junyong Zhao, Qiang Shen, Lin Fang. Mol Cell Biochem 2018
27
11

MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3.
Chengling Chu, Xin Liu, Xue Bai, Tong Zhao, Mengxue Wang, Ranchen Xu, Mingqi Li, Yingying Hu, Weihua Li, Lida Yang,[...]. Int J Biol Sci 2018
30
11

miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
Yue Yu, Wei Luo, Zheng-Jun Yang, Jiang-Rui Chi, Yun-Rui Li, Yu Ding, Jie Ge, Xin Wang, Xu-Chen Cao. Mol Cancer 2018
81
11

Dysregulated miR-183 inhibits migration in breast cancer cells.
Aoife J Lowery, Nicola Miller, Roisin M Dwyer, Michael J Kerin. BMC Cancer 2010
109
11


Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.
Hadi Valadi, Karin Ekström, Apostolos Bossios, Margareta Sjöstrand, James J Lee, Jan O Lötvall. Nat Cell Biol 2007
11

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
11

Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues.
Marcela Julio-Pieper, Peter J Flor, Timothy G Dinan, John F Cryan. Pharmacol Rev 2011
130
11

GRM4 inhibits the proliferation, migration, and invasion of human osteosarcoma cells through interaction with CBX4.
Zengliang Zhang, Nan Li, Xing Wei, Bingyao Chen, Yinglong Zhang, Yantao Zhao, Xiantong Hu, Shuxun Hou. Biosci Biotechnol Biochem 2020
3
66

Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas.
Luisa Iacovelli, Antonietta Arcella, Giuseppe Battaglia, Simonetta Pazzaglia, Eleonora Aronica, Paola Spinsanti, Alessandra Caruso, Enrico De Smaele, Anna Saran, Alberto Gulino,[...]. J Neurosci 2006
65
11

Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.
Francesca Fallarino, Claudia Volpi, Francesco Fazio, Serena Notartomaso, Carmine Vacca, Carla Busceti, Silvio Bicciato, Giuseppe Battaglia, Valeria Bruno, Paolo Puccetti,[...]. Nat Med 2010
110
11

Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways.
L Iacovelli, V Bruno, L Salvatore, D Melchiorri, R Gradini, A Caricasole, E Barletta, A De Blasi, F Nicoletti. J Neurochem 2002
100
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.